Revitalizing Hair Growth: A New Regimen Utilizing Growth Factor Concentrate for Hair Loss Treatment.
Abstract
Androgenic alopecia is a common and major cause of progressive hair loss. Hair loss can be prevented by administrating concentrated growth factor concentrate (GFC) into the scalp where the person's own growth factors are effectively delivered deep within the layers of the scalp, promoting optimal results. This prospective study includes five patients with androgenic alopecia. Growth factor concentrates were injected subcutaneously into the scalp, and assessment was done before the procedure two and eight weeks after the first sitting. The treatment outcome was evaluated with macroscopic and trichoscopic microphotographs. The trichoscopic microphotographs provided further evidence of the notable improvement in hair density. Additionally, the hair pull test yielded negative results during the eight-week follow-up, confirming the positive outcomes of the GFC treatment. Patients were highly satisfied with the results: faster rate of hair growth, better quality of hair, and minimal side effects.
TL;DR
Patients with androgenic alopecia received concentrated growth factor concentrate into the scalp where the person's own growth factors are effectively delivered deep within the layers of the scalp, promoting optimal results.
Used In Evidence Reviews
Similar Papers
Journal of cosmetic dermatology · 2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Stem cells translational medicine · 2015
The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial.
Clinical reviews in allergy & immunology · 2021
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Cells · 2019
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.
The British journal of dermatology · 2013
A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2018